Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Judge Ward isn't going to think anything

Doesn't the 50% patent holder, TPL, have competing products?

 

"Lastly, as you have stated in the past, he agreed that PTSC has minimal chance of getting an injunction against ARM/J3. Main reason being that PTSC does not produce a product therefore defendants are not producing a competing product."

 

 

Be well

Share
New Message
Please login to post a reply